Philogen Provides Corporate Update
Publish date: Nov 12, 2021 2:00 AM EST Philogen Provides Corporate Update Nidlegy ™ and Fibromun are on track with planned timelines in pivotal clinical trials Fibromun shows potent activity in last-line glioblastoma in combination with Lomustine The OncoFAP platform shows promising results... Philogen Provides Corporate Update Nidlegy ™ and…
bubmagNovember 12, 2021